Development of potent and selective blockers of acid sensing ion channels for the treatment of pain (2011-2013)

Experts

Professor Glenn King

NHMRC Leadership Fellow and Group Leader: Institute for Molecular Bioscience

Affiliate of Centre for Cardiovascular Health and Research: Centre for Cardiovascular Health and Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR): Centre for Innovation in Pain and Health Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate Professor of School of Chemistry and Molecular Biosciences: School of Chemistry and Molecular Biosciences; Faculty of Science

Affiliate of The Centre for Chemistry and Drug Discovery: Centre for Chemistry and Drug Discovery; Institute for Molecular Bioscience

Affiliate of ARC COE for Innovations in Peptide and Protein Science: ARC COE for Innovations in Peptide and Protein Science; Institute for Molecular Bioscience

Glenn King

Glenn King

Professor Alan Mark

Affiliate of Centre for Organic Photonics and Electronics: Centre for Organic Photonics and Electronics; Faculty of Science

Affiliate of ARC COE in Quantum Biotechnology (QUBIC): ARC COE in Quantum Biotechnology; Faculty of Science

Affiliate of ARC COE for Innovations in Peptide and Protein Science: ARC COE for Innovations in Peptide and Protein Science; Institute for Molecular Bioscience

Professor: School of Chemistry and Molecular Biosciences; Faculty of Science

Alan Mark

Alan Mark

Dr Lachlan Rash

Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR): Centre for Innovation in Pain and Health Research; Faculty of Health, Medicine and Behavioural Sciences

Associate Professor: School of Biomedical Sciences; Faculty of Health, Medicine and Behavioural Sciences

Lachlan Rash

Lachlan Rash